Core Insights - The SCCM Enhanced Equity Income Fund reported a composite return of 0.9% in Q3 2025, underperforming compared to the S&P 500 Buy-Write Index which returned 3.5% [1] - Baxter International Inc. (NYSE:BAX) was highlighted as a significant stock, with a one-month return of 2.67% and a 52-week gain of 41.89% [2] - The fund exited its position in Baxter due to ongoing challenges, including a 40% dividend cut and operational issues, despite recognizing its long-term recovery potential [3] Fund Performance - The S&P 500 returned 8.1% in Q3 2025, while the Russell 1000 Value increased by 5.3% [1] - The fund's performance was notably lower than the S&P 500 Buy-Write Index, which returned 3.5% [1] Baxter International Inc. Analysis - Baxter's stock closed at $18.48 on December 4, 2025, with a market capitalization of $9.5 billion [2] - The company faced significant challenges post-COVID, including margin pressure and pricing issues from hospital Group Purchasing Organizations [3] - Management's decision to cut the dividend by 40% and change the CEO indicates ongoing financial struggles [3] Hedge Fund Interest - Baxter International Inc. was held by 38 hedge fund portfolios at the end of Q3 2025, an increase from 31 in the previous quarter [4] - Despite its potential, analysts suggest that certain AI stocks may offer better investment opportunities with less risk [4]